Author

Nada Farah Page 5

Nada Farah, AGPCNP-BC, OCN, is a nurse practitioner at an academic molecular tumor board clinic in Columbia, Missouri. She has worked in oncology for 16 years, beginning in outpatient medical oncology and thoracic cancer care before subspecializing in precision medicine. Farah reviews genomic profiling reports with patients to explain specific mutations and potential targeted therapies. She writes about tumor biomarkers and targeted drug therapies. She earned her doctor of nursing practice from Duke University.

NTRK Fusion: Its Role in Cancer and Targeted Therapy
What Is a RET Fusion and What Does It Mean for Cancer?
Germ Cell Tumor Markers: Their Role in Cancer Care
What Is FOLR1’s Role in Ovarian Cancer?
What Is the EGFR T790M Mutation in Lung Cancer?
PD-L1 in Lung Cancer: What It Is and Why It Matters
What Is HER3 and Its Role in Cancer and Treatment?
What Does a Microsatellite Stable Tumor Mean?
What Is Molecular Residual Disease in Cancer Treatment?
HER2 Amplification: Cancer Diagnosis and Targeted Therapy
What Is KRAS G12C Genetic Testing for Cancer?
Grid Therapeutics: What to Know About This Cancer Therapy
MSI-High Prostate Cancer: Diagnosis, Treatment, and Outlook
HER2 Amplification vs. Overexpression: What’s the Difference?
Why EGFR Mutation Lung Cancer Is More Common in Asians
The Role of mRNA Therapies in Breast Oncology
MYOD1 Rhabdomyosarcoma: Genetics, Diagnosis & Treatment
NRAS Melanoma: Diagnosis, Treatments, and Prognosis
What Are the Key Small Cell Lung Cancer Mutations?
What Does It Mean to Have RET-Positive Cancer?
What Is PD-L1 TPS and Why Does It Matter for Cancer?
dMMR Cancer: Diagnosis, Treatment, and Prognosis
ALK Fusion: Cancers, Detection, and Targeted Therapy
What is GlycoStem’s Off-the-Shelf NK Cell Therapy?
What is the CCND1 Gene and Its Role in Cancer?
TNBC Subtypes: Classification, Prognosis, and Treatment
EGFR Amplification: What It Is and Why It Matters in Cancer
What Is the EGFR Exon 21 Mutation in Lung Cancer?
How PD-L1 Impacts Lung Cancer Survival
Long Term Side Effects of CAR T-Cell Therapy